Bioactive Lipids and Lipidomics 2018

doi:10.3390/books978-3-03936-277-6

Reprint

Bioactive Lipids and Lipidomics 2018

Edited by

August 2020

296 pages

ISBN978-3-03936-276-9 (Hardback)
ISBN978-3-03936-277-6 (PDF)

https://doi.org/10.3390/books978-3-03936-277-6

Free download (PDF)

This book is a reprint of the Special Issue Bioactive Lipids and Lipidomics 2018 that was published in

Biology & Life Sciences

Chemistry & Materials Science

Medicine & Pharmacology

Summary

After the coming of age of lipidomics, the science of global lipid analysis has broadened its contribution to the understanding of biological processes. This volume represents a transversal view on the state of the art of research on lipid biology and bioactive lipid molecules. It includes research and review articles on the role of bioactive lipids in diverse domains like cell signaling, neuromuscular transmission, cancer pathophysiology, cardiovascular and rare diseases, antibacterial activity, the emergency of biomaterials, and associated technological and analytical developments. It provides an instantaneous picture of the place of lipidomics and its fields of application, as well as hints about the directions that lipid research may follow in the near future.

Format

Hardback

License

Keywords

outer membrane vesicles; lipidomics; Gram-negative; polymyxin; extremely drug resistant; resolvin; lipoxin; cystic fibrosis; GBA2; non-lysosomal β-glucosylceramidase; β-glucocerebrosidase; spastic ataxia; glucosylceramide; plasma membrane; lymphoblastoid cell lines; integrin signalling; lipid raft-mediated internalization; hepatic fibrosis; lipidomics; isotopic profiling; metabolic reprogramming; IDH mutation; leukemia; extracellular vesicles; oncogene-induced senescence; H-Ras; fatty acids; desaturases; elongases; acyl-coenzyme A synthetases; PPAR; statins; fibrates; cholesterol; viruses; cancer; fatty acids; ascorbyl palmitate; mono and diglycerides of fatty acids; natural lipophilic compounds; nutraceutical products; Serenoa repens oil; enteric bioaccessibility; skeletal muscle; neuromuscular transmission; safety factor; cholesterol and lipid rafts; oxysterols; synaptic vesicle cycle; quantal release; Na,K-ATPase; nicotinic acetylcholine receptor; oxidized phospholipids; oxylipins; bioactive lipids; coronary disease; myocardial infarction; ischemic heart disease; ischemia reperfusion injury; mass spectrometry; lipids; hydroxyacyl-phenylalanine; lipoamino acid; entomopathogen; bacteria; antimicrobial; larvicidal; Aedes aegypti; MARK4; pig; lipogenesis; placenta; WNT; molecular cloning; PPARγ; MALDI-TOF; TOF-SIMS; glomerulopathies; nephrotic syndrome; MSI; Astrocaryum sciophilum; endophytes; molecular networking; antibacterial; cytotoxicity; fatty acids; AML; immune therapy; PGE2; omega-3; omega-6; lipidomics; n/a; Cyclooxygenase; skeletal muscle; myogenic differentiation; lipidomics